Hoth Therapeutics, Inc. — Director's Dealing 2020

Jul 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2020-07-21

Reporting Person: Knie Robb (Director, CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-21	Options	$3.05	A	80000	Acquired	2030-07-21	Common Stock (80000)	Direct

Footnotes

F1: The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.